The multiple negative randomized controlled trials in perinatology - Why?

Seminars in Perinatology

Volumn 27, Issue 4, 2003, Pages 343-350

  Strand, Marya ^a   Jobe, Alan H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ERYTHROPOIETIN; IMMUNOGLOBULIN; INDOMETACIN; PHENOBARBITAL; RETINOL; XIPAMIDE;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG FORMULATION; DRUG MECHANISM; HOSPITAL INFECTION; HUMAN; LOW DRUG DOSE; LUNG DYSPLASIA; META ANALYSIS; METHODOLOGY; NEWBORN; NEWBORN DISEASE; NEWBORN INFECTION; OINTMENT; PATIENT CARE; PERINATOLOGY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0041917674     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(03)00042-9     Document Type: Article

References (44)

1. Sinclair JC, Bracken MBE: Effective care of the newborn infant, Oxford, Oxford University Press, 1992
2. Sinclair J: Assessing evidence concerning treatment and prevention of diseases of the newborn, in Sinclair J, Bracken M (eds): Assessing Evidence Concerning Treatment and Prevention of Diseases of the Newborn Oxford, Oxford University Press, 1992, pp 3-12
3. Stark AR, Carlo WA, Tyson JE, Papile LA, et al: Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 344:95-101, 2001
4. Carlo WA, Stark AR, Wright LL, et al: Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. J Pediatr 141:370-374, 2002
5. Group HS: High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 320:88-93, 1989
6. Plavka R, Kopecky P, Sebron V, et al: A prospective randomized comparison of conventional mechanical ventilation and very early high frequency oscillatory ventilation in extremely premature newborns with respiratory distress syndrome. Intens Care Med 25:68-75, 1999
7. Clark RH, Gerstmann DR, Null DM, Jr, et al: Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 89:5-12, 1992
8. Group HS: Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J Pediatr 122:609-619, 1993
9. Courtney SE, Durand DJ, Asselin JM, et al: High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 347:643-652, 2002
10. Johnson AH, Peacock JL, Greenough A, et al: High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 347: 633-642, 2002
11. Fanaroff AA, Korones SB, Wright LL, et al: A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 330:1107-1113, 1994
12. Sandberg K, Fasth A, Berger A, et al: Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr 137:623-628, 2000
13. Sapsford A: Parenteral nutrition: energy, carbohydrate, protein, and fat, in Groh-Wargo S, Thompson M, Cox J, (ed): Parenteral Nutrition: Energy, Carbohydrate, Protein, and Fat. Chicago, IL, Precept Press, Inc, 2000, p. 128
14. Griffiths RD, Jones C, Palmer TE: Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13:295-302, 1997
15. Ziegler TR, Young LS, Benfell K, et al: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116:821-828, 1992
16. Lacey JM, Crouch JB, Benfell K, et al: The effects of glutamine-supplemented parenteral nutrition in premature infants. JPEN J Parenter Enteral Nutr 20:74-80, 1996
17. Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Parenteral glutamine supplementation in ELBW infants: a multicenter randomized trial. Pediatr Res 51:317A, 2002
18. Morales WJ, Koerten J: Prevention of intraventricular hemorrhage in very low birth weight infants by maternally administered phenobarbital. Obstet Gynecol 68: 295-299, 1986
19. De Carolis S, De Carolis MP, Caruso A, et al: Antenatal phenobarbital in preventing intraventricular hemorrhage in premature newborns. Fetal Ther 3:224-229, 1988
20. Kaempf JW, Porreco R, Molina R, et al: Antenatal phenobarbital for the prevention of periventricular and intraventricular hemorrhage: a double-blind, randomized, placebo-controlled, multihospital trial. J Pediatr 117:933-938, 1990
21. Horbar J: Prevention of periventricular-intraventricular hemorrhage, in Sinclair J, Bracken M (eds): Prevention of Periventricular-intraventricular Hemorrhage Oxford, Oxford University Press, 1992, pp 562-589
22. Shankaran S, Papile L, Wright LL, et al: The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 337: 466-471, 1997
23. Wimberley PD, Lou HC, Pedersen H, et al: Hypertensive peaks in the pathogenesis of intraventricular hemorrhage in the newborn: Abolition by phenobarbitone sedation. Acta Paediatr Scand 71:537-542, 1982
24. Edwards W, Conner JM, Soll RF: The effects of Aquaphor original ointment on nosocomial sepsis rates and skin integrity in infants of birth wieght 501 to 1000 grams. Pediatr Res 50:388A, 2001
25. Nopper AJ, Horii KA, Sookdeo-Drost S, et al: Topical ointment therapy benefits premature infants. J Pediatr 128:660-669, 1996
26. Harrold J, Schmidt B: Evidence-based neonatology: Making a difference beyond discharge from the neonatal nursery. Curr Opin Pediatr 14:165-169, 2002
27. Zhang B, Schmidt B: Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials. J Pediatr 138: 76-80, 2001
28. Hanigan WC, Kennedy G, Roemisch F, et al: Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr 112:941-947, 1988
29. Ment LR, Oh W, Ehrenkranz RA, et al: Low-dose indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial. Pediatrics 93: 543-550, 1994
30. Mahony L, Carnero V, Brett C, et al: Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 306:506-510, 1982
31. Bandstra ES, Montalvo BM, Goldberg RN, et al: Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 82:533-542, 1988
32. Krueger E, Mellander M, Bratton D, et al: Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 111:749-754, 1987
33. Schmidt B, Davis P, Moddemann D, et al: Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344:1966-1972, 2001
34. Ment LR, Vohr B, Allan W, et al: Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 105:485-491, 2000
35. Strathearn L, Gray PH, O'Callaghan F, et al: Childhood neglect and cognitive development in extremely low birth weight infants: a prospective study. Pediatrics 108: 142-151, 2001
36. Escalona SK: Babies at double hazard: Early development of infants at biologic and social risk. Pediatrics 70:670-676, 1982
37. Gross S, Mettelman B, Dye T, et al: Impact of family structure and stability on academic outcome in preterm children at 10 years of age. J Pediatr 138:169-175, 2001
38. Maier RF, Obladen M, Scigalla P, et al: The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 330:1173-1178, 1994
39. Ohls RK: Erythropoietin treatment in extremely low birth weight infants: Blood in versus blood out. J Pediatr 141:3-6, 2002
40. Synnes AR, Chien LY, Peliowski A, et al: Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units. J Pediatr 138:525-531, 2001
41. Lemons JA, Bauer CR, Oh W, et al: Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107:E1, 2001
42. Tyson JE, Wright LL, Oh W, et al: Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 340:1962-1968, 1999
43. Shenai JP, Kennedy KA, Chytil F, et al: Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 111:269-277, 1987
44. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22, 2002